Paris Appeals Court Backs €40.6M Antitrust Fine For Sanofi
Law360, New York (December 22, 2014, 6:48 PM EST) -- A Paris appeals court has upheld a €40.6 million ($49.7 million) antitrust fine against Sanofi SA for campaigning to discourage doctors and pharmacists from prescribing or substituting generic versions of its former blockbuster blood thinner Plavix.
The Court of Appeals of Paris on Thursday rejected Sanofi's appeal of a May 2013 decision by the French Competition Authority fining the drugmaker for abusing its dominance and using a “strategy of denigration” against generic Plavix competitors in 2009 and 2010.
The court concluded that Sanofi had dominance in the market for the drug in France and had abused that dominance through the practices...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!